Funding · Company
Dash Bio, Inc.
Boston, MAHealthcare
Dash Bio, Inc. of Boston, MA has disclosed $30M across 1 Form D offering filed with the SEC on Jul 14, 2026.
$30M
Total disclosed
1
Form D offering
2024
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersBoston, MAIndustryHealthcare (Other Health Care)Incorporated2024SEC CIK0002041370Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →